Literature DB >> 239358

Effect of correction of metabolic acidosis on bone mineralisation rates in patients with renal osteomalacia.

M Cochran, R Wilkinson.   

Abstract

The role of metabolic acidosis in the genesis of renal osteomalacia was investigated by studying bone mineralisation and resorption rates with a combined isotope and balance technique in six patients, before and after the administration of alkali. Correction of blood pH was achieved in five cases and was associated with a significant rise in the bone mineralisation rates and a significant positive trend in the calcium balances. It is suggested that acidosis contributes to the pathogenesis of osteomalacia in renal failure by slowing skeletal mineralisation, possibly by inhibiting bone alkaline phosphatase.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 239358     DOI: 10.1159/000180501

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  12 in total

Review 1.  Correction of chronic metabolic acidosis for chronic kidney disease patients.

Authors:  P Roderick; N S Willis; S Blakeley; C Jones; C Tomson
Journal:  Cochrane Database Syst Rev       Date:  2007-01-24

Review 2.  Dietary acid load: a novel nutritional target in chronic kidney disease?

Authors:  Julia J Scialla; Cheryl A M Anderson
Journal:  Adv Chronic Kidney Dis       Date:  2013-03       Impact factor: 3.620

Review 3.  Role of extremophiles and their extremozymes in biorefinery process of lignocellulose degradation.

Authors:  Dixita Chettri; Ashwani Kumar Verma; Lija Sarkar; Anil Kumar Verma
Journal:  Extremophiles       Date:  2021-03-25       Impact factor: 2.395

Review 4.  Osteomalacia and chronic renal failure.

Authors:  J A Kanis
Journal:  J Clin Pathol       Date:  1981-11       Impact factor: 3.411

Review 5.  Effects of acid on bone.

Authors:  David A Bushinsky; Nancy S Krieger
Journal:  Kidney Int       Date:  2022-03-26       Impact factor: 18.998

Review 6.  Consequences and therapy of the metabolic acidosis of chronic kidney disease.

Authors:  Jeffrey A Kraut; Nicolaos E Madias
Journal:  Pediatr Nephrol       Date:  2010-06-05       Impact factor: 3.714

7.  Metabolic acidosis in patients receiving anticonvulsants.

Authors:  B Nagai; I Matsuda; T Kondo; N Taniguchi; S Arashima; T Mitsuyama; Y Oka; M Honma
Journal:  Eur J Pediatr       Date:  1979-11       Impact factor: 3.183

8.  Randomized, Controlled Trial of TRC101 to Increase Serum Bicarbonate in Patients with CKD.

Authors:  David A Bushinsky; Thomas Hostetter; Gerrit Klaerner; Yuri Stasiv; Claire Lockey; Sarah McNulty; Angela Lee; Dawn Parsell; Vandana Mathur; Elizabeth Li; Jerry Buysse; Robert Alpern
Journal:  Clin J Am Soc Nephrol       Date:  2017-11-04       Impact factor: 8.237

9.  Haemodynamic consequences of changing bicarbonate and calcium concentrations in haemodialysis fluids.

Authors:  Luca Gabutti; Giorgia Bianchi; Davide Soldini; Claudio Marone; Michel Burnier
Journal:  Nephrol Dial Transplant       Date:  2008-10-08       Impact factor: 5.992

10.  Approximation of bicarbonate concentration using serum total carbon dioxide concentration in patients with non-dialysis chronic kidney disease.

Authors:  Keiji Hirai; Saori Minato; Shohei Kaneko; Katsunori Yanai; Hiroki Ishii; Taisuke Kitano; Mitsutoshi Shindo; Haruhisa Miyazawa; Kiyonori Ito; Yuichirou Ueda; Yoshio Kaku; Taro Hoshino; Tatsuro Watano; Shinji Fujino; Susumu Ookawara; Kiyoka Omoto; Yoshiyuki Morishita
Journal:  Kidney Res Clin Pract       Date:  2019-09-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.